Following publication, the authors contacted the Editorial Office stating that concerns were raised regarding the scientific validity of the article. In particular, the authors stated that the case presented in the article was not adequate to strongly support their conclusion. Additionally, they stated that the discussion section required further, updated literature, and that the authors were planning to perform additional experiments to support their conclusions.
The authors failed to provide any further explanation since their initial correspondence. As a result, and following an investigation conducted in accordance with Pathology and Oncology Research policies by the editorial board, the conclusions of the article have been deemed unreliable and the article has been retracted.
This retraction was approved by the Editor-in-Chief of Pathology and Oncology Research. The authors received communication regarding the retraction but did not finalize their agreement. The communication has been recorded by the publisher.
Summary
Keywords
breast cancer, Clear cell renal cell carcinoma, tumor-to-tumor metastasis, rare case, metastatic lobular breast carcinoma
Citation
Pathology and Oncology Research Editorial Office (2024) Retraction: Case report: A rare case of tumor-to-tumor metastasis: metastatic lobular breast carcinoma to clear cell renal cell carcinoma. Pathol. Oncol. Res. 30:1611784. doi: 10.3389/pore.2024.1611784
Received
28 March 2024
Accepted
28 March 2024
Published
05 April 2024
Approved by
József Tímár, Semmelweis University, Hungary
Volume
30 - 2024
Updates
Copyright
© 2024 Pathology and Oncology Research Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pathology and Oncology Research Editorial Office, editorialoffice@por-journal.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.